Browsing by Author Brew, B.J. (Bruce)

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 12 of 12
Issue DateTitleAuthor(s)Citation
2007Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-monoinfected and HIV/HCV-coinfected individuals commencing HCV treatmentKoorey, David; Brew, B.J. (Bruce); Dore, Gregory J.; Kaldore, John; Krahn, M; Maruff, Paul; Thein, Hla Hla; Central Clinical School: MedicineCognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-monoinfected and HIV/HCV-coinfected individuals commencing HCV treatment, HIV Medicine, vol.8,(3),2007,pp 192-202
2009Evidence for predilection of macrophage infiltration patterns in the deeper midline and mesial temporal structures of the brain uniquely in patients with HIV-associated dementiaHo, Yung; Rua, Rejane; Saksena, Nitin; Vongrad, Valentina; Zhou, Li; Brew, B.J. (Bruce); Geczy, Carolyn; Hsu, Kenneth; Ng, Thomas; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteEvidence for predilection of macrophage infiltration patterns in the deeper midline and mesial temporal structures of the brain uniquely in patients with HIV-associated dementia, BMC Infectious Diseases, vol.9, N/A,pp 192-1-192-14
2009The excitotoxin quinolinic acid induces tau phosphorylation in human neuronsCullen, Karen; Braidy, Nady; Brew, B.J. (Bruce); Guillemin, Gilles; Rahman, Abdur; Ting, Kaka; School of Medical Sciences: Anatomy & HistologyThe excitotoxin quinolinic acid induces tau phosphorylation in human neurons, PLoS One, vol.4, 7, 2009,pp e6344 - 1-e6344 - 15
2004Independent Evolution Of Human Immunodeficiency Virus (Hiv) Drug Resistance Mutations In Diverse Areas Of The Brain In Hiv-Infected Patients, With And Without Dementia, On Antiretroviral Treatment.Saksena, Nitin; Smit, T; Brew, B.J. (Bruce); Gelman, Benjamin B.; Morgello, Susan; Tourtellotte, Wallace; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)Independent Evolution Of Human Immunodeficiency Virus (Hiv) Drug Resistance Mutations In Diverse Areas Of The Brain In Hiv-Infected Patients, With And Without Dementia, On Antiretroviral Treatment., Journal of Virology, vol.78,(18),2004,pp 10133-10148
2010The Kynurenine Pathway and Inflammation in Amyotrophic Lateral Sclerosis.Cullen, Karen; Stankovic, Roger; Brew, B.J. (Bruce); Chen, Y; Coggan, S; Garner, Brett; Grant, Ross S.; Guillemin, Gilles; Meininger, V; School of Medical Sciences: Anatomy & Histology; School of Medical Sciences: School of Medical SciencesThe Kynurenine Pathway and Inflammation in Amyotrophic Lateral Sclerosis., Neurotoxicity Research, vol.18, 2,pp 132-142
2008Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance & neurotoxicityArmati, Patricia; Brew, B.J. (Bruce); Crowe, Suzanne M; Mukhtar, Muhhammad; Owe-Young, Robert; Pomerantz, Roger J; Smythe, G; Walker, David; Webster, Nicole L; School of Medical Sciences: Brain & Mind Research InstituteKynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance & neurotoxicity, Journal of Neurochemistry, vol.105, 4, 2008,pp 1346-1357
2006Neural transplantation of human MSC and NT2 cells in the twitcher mouse modelTaylor, Rosanne; Ajami, B; Brew, B.J. (Bruce); Croitoru-Lamoury, J; Lamoury, F.M.J.; Veas, L.A.; Williams, K.R.; Vet Science FacultyNeural transplantation of human MSC and NT2 cells in the twitcher mouse model, Cytotherapy, vol.8,(5),2006,pp 445-458
2015A new era in the treatment of multiple sclerosisBarnett, Michael; Heard, Robert; Parratt, John Douglas; Pollard, John; Reddel, S; Spies, Judith; Boggild, Mike; Brew, B.J. (Bruce); Broadley, Simon; Butzkueven, Helmut; et al, Various; Hodgkinson, Suzanne; Kermode, Allan; Lechner-Scott, Jeannette; Macdonell, Richard A.L.; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Central Clinical School: Medicine; Medicine; Central Clinical School: MedicineA new era in the treatment of multiple sclerosis, Medical Journal of Australia, vol.203, 3, 2015,pp 139-141
2014Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapiesBarnett, Michael; Heard, Robert; Parratt, John Douglas; Pollard, John; Reddel, Stephen; Spies, Judith; Boggild, Mike; Brew, B.J. (Bruce); Broadley, Simon; Butzkueven, Helmut; et al, Various; Hodgkinson, Suzanne J.; Kermode, Allan; Lechner-Scott, Jeannette; Macdonell, Richard A.L.; Marriott, Mark; Mason, Deborah F.; Shaw, Cameron P.; Slee, Mark; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Central Clinical School: MedicineTherapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies, Journal of Clinical Neuroscience, vol.21, 11, 2014,pp 1835-1846
2014Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacyBarnett, Michael; Heard, Robert; Parratt, John Douglas; Pollard, John; Reddel, Stephen; Spies, Judith; Boggild, Mike; Brew, B.J. (Bruce); Broadley, Simon; Butzkueven, Helmut; et al, Various; Hodgkinson, Suzanne J.; Kermode, Allan; Lechner-Scott, Jeannette; Macdonell, Richard A.L.; Marriott, Mark; Mason, Deborah F.; Shaw, Cameron P.; Slee, Mark; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Central Clinical School: MedicineTherapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy, Journal of Clinical Neuroscience, vol.21, 11, 2014,pp 1847-1856
2014Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendationsBarnett, Michael; Heard, Robert; Parratt, John Douglas; Pollard, John; Reddel, Stephen; Spies, Judith; Boggild, Mike; Brew, B.J. (Bruce); Broadley, Simon; Butzkueven, Helmut; et al, Various; Hodgkinson, Suzanne J.; Kermode, Allan; Lechner-Scott, Jeannette; Macdonell, Richard A.L.; Marriott, Mark; Mason, Deborah F.; Shaw, Cameron P.; Slee, Mark; Taylor, Bruce V.; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Central Clinical School: MedicineTherapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations, Journal of Clinical Neuroscience, vol.21, 11, 2014,pp 1857-1865
2006Transcriptional activity of blood-and cerebrospinal fluid-derived nef/long-terminal repeat sequences isolated from a slow progressor infected with nef-deleted human immunodeficiency virus type 1 (HIV-1) who developed HIV-associated dementia.Sullivan, John; Brew, B.J. (Bruce); Churchill, Melissa J.; Cowley, Daniel; Figueiredo, Anna; Gorry, Paul R.; Gray, Leonard; McPhee, Dale A.; Purcell, Damian F J; Wesselingh, Steven L.; Central Clinical School: MedicineTranscriptional activity of blood-and cerebrospinal fluid-derived nef/long-terminal repeat sequences isolated from a slow progressor infected with nef-deleted human immunodeficiency virus type 1 (HIV-1) who developed HIV-associated dementia., Journal of neurovirology, vol.12,(3),2006,pp 219-228